patient access

Market Access

Beyond the Bill: how do we make medicines affordable without...

Two pharmaceutical giants have paused investment in the UK. More than a setback for British life sciences, it’s a warning sign for the future.

R&D

pharmaphorum podcast Episode 207a, Brandon Pence

The importance of being disruption ready, with Brandon Pence

Brandon Pence, recently appointed President and COO of Fujifilm Biosciences, discusses the cell culture media industry and being disruption ready.

Patients

Frontiers Health limited series podcast, Roberta Sarno

FH25: On patient access and equity, with Roberta Sarno

In another episode of our limited Frontiers Health series of the pharmaphorum podcast, we speak with founder, director, and global health advisor.

Patients

Do we need to rethink the role of private healthcare in pati...

Timely patient access to medication has become an acute problem in the UK healthcare system, with patients often caught in a tug-of-war between an overburdened NHS and the high costs of tra

Market Access

Part Two: Navigating the complexities of global market acces...

The journey to global market access for innovative therapies is fraught with challenges that vary significantly across the world.

Market Access

Seizing the moment: The life sciences industry at the thresh...

The passage of the Inflation Reduction Act (IRA) signifies more than just a legislative milestone; it acts as a clarion call to the pharmaceutical industry.

Beyond the Bill: how do we make medicines affordable without...

The importance of being disruption ready, with Brandon Pence

FH25: On patient access and equity, with Roberta Sarno

Do we need to rethink the role of private healthcare in pati...

Part Two: Navigating the complexities of global market acces...

Seizing the moment: The life sciences industry at the thresh...

NHS staff 'feel unprepared for digital transformation'

How to meet your physicians where they are online

patient access

Editor's Picks